期刊文献+

儿童扩张性心肌病合并心室内血栓2例临床分析及文献回顾 被引量:1

Children dilated cardiomyopathy complicated ventricular thrombus two cases of clinical analysis and review of the literature
下载PDF
导出
摘要 目的探讨儿童扩张性心肌病形成心室内血栓高危因素、治疗方法及预后。方法回顾性分析河南省郑州市儿童医院2013~2015年收治2例扩张性心肌病合并心室内血栓的临床资料,并进行文献复习。结果2例患儿平素均未规律服用改善心功能药物及抗凝药物。病例1,女,6岁8个月,同时给予肝素、阿司匹林、华法林联合抗凝治疗12天,血栓吸收顺利,随访6个月,未出现血栓。例2,男,6岁2个月,先给予肝素抗凝,出院前加用华法林,住院56天后血栓吸收,期间出现脑梗死,随访2个月,未出现血栓。结论不规范治疗是儿童扩张性心肌病发生心室内血栓的重要高危因素;定期随访、规范服用改善心功能及抗凝药物,积极处理并发症,有助于改善预后。 Objective To investigate ventricular thrombosis of risk factors,treatment and prognosis in children of dilated cardiomyopathy.Method A retrospective analysis of clinical data of 2 cases of dilated cardiomyopathy complicated ventricular thrombi in Children's Hospital of Zhengzhou in 2013—2015 years,and review related literature.Result Two cases are not usually regular use of drugs to improve heart function and anticoagulant drugs.Example1,female,6 years and 8 months,heparin,aspirin,warfarin were been used for 12 days,thrombus were absorbed,after 6 months of follow-up,no recurrence.Example 2,male,6 years and 2 months,First giving heparin was been used first,and then warfarin was been given,After 56 days of hospitalization thrombosis absorbed,cerebral infarction occurred,after 2 months of follow-up,no recurrence.Conclusion No standard treatment is an important risk factor for child dilated cardiomyopathy ventricular thrombus;Regulate following-up,taking drugs of improving heart function and anticoagulant,activly treating complications can help to improve the prognosis
出处 《中国临床医生杂志》 2017年第1期42-44,共3页 Chinese Journal For Clinicians
基金 上海市科学技术委员会资助项目(16411972500)
关键词 扩张性心肌病 心室内血栓 心功能 抗凝 Dilated cardiomyopathy Ventricular thrombus Heart function Anticoagulation
  • 相关文献

参考文献7

二级参考文献75

  • 1卢永昕.心力衰竭神经内分泌治疗的现代观念[J].中国医刊,2006,41(5):14-16. 被引量:46
  • 2胡大一,马长生.心脏病学实践[M].北京:人民卫生出版社,2009:149-150.
  • 3Maron B J, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee;Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups: and Council on Epidemiology and Prevention [J]. Circulation, 2006,113(14) : 1807-1816.
  • 4Solheim S, Seljeflot I, Lunde K, et al. Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy [J]. Am J Cardiol, 2010,106(9) : 1197-1200.
  • 5Jefferies JL, Towbin JA. Dilated cardiomyopathy[J]. Lancet, 2010,375(9716) :752-762.
  • 6Abdo AS, Kemp R, Barham J, et al. Dilated cardiomyopathy and role of antithrombotic therapy[J]. Am J Med Sci, 2010, 339(6):557- 560.
  • 7Ozdemir N, Kaymaz C, Daglar E, et al. Severe mitral regurgitation may prevent mural thrombus formation within the left ventricle with systolic dysfunction[J]. Jpn Heart J, 2002,43(5) :495- 503.
  • 8Aleksova A, Sabbadini G, Merlo M, et al. Natural history of dilated eardiomyopathy: from asymptomatie left ventricular dysfunction to heart failure-a subgroup analysis from the Trieste Cardiomyopathy Registry [J].J Cardiovasc Med (Hagerstown) ,2009,10(9) :699-705.
  • 9胡大一,柯元南,颜红兵,等.临床冠心病诊断与治疗指南[M].北京:人民卫生出版社,2010:100-109.
  • 10Hobbs RE,Mills RM.Endogenous B-type natriuretic peptide:a limb of the regulatory response to acutely decompensated heart failure[J].Clin Cardiol,2008,31(9):407-412.

共引文献51

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部